Petros Pharmaceuticals | EFFECT:其他
Petros Pharmaceuticals | 10-Q:季度报表
Petros Pharmaceuticals | S-3:特定交易注册声明
Petros Pharmaceuticals | 10-K:年度报表
Petros Pharmaceuticals | 8-K:重大事件
Petros Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%)
Petros Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Mitchell P. Kopin(6.6%),Daniel B. Asher(6.6%)等
Petros Pharmaceuticals | 8-K:重大事件
Petros Pharmaceuticals | 8-K:重大事件
Petros Pharmaceuticals | 8-K:重大事件
Petros Pharmaceuticals | 4:持股变动声明-董事 Bernstein Bruce
Petros Pharmaceuticals | 4:持股变动声明-高管 Boctor Fady
Petros Pharmaceuticals | 4:持股变动声明-董事 WALKER WAYNE REMELL
Petros Pharmaceuticals | 4:持股变动声明-高管 Arnold Mitchell
Petros Pharmaceuticals | 4:持股变动声明-董事 Silverman Joshua
Petros Pharmaceuticals | 4:持股变动声明-董事 Bradley Greg
Petros Pharmaceuticals | ARS:年度报告
Petros Pharmaceuticals | DEF 14A:股东委托书决议
Petros Pharmaceuticals:2023财年三季报
Petros Pharmaceuticals | NT 10-Q:季报延迟披露公告
暂无数据